Interleukin-2 gene therapy of surgical minimal residual tumour disease.

Abstract:

:Our study was designed to examine the effects of IL-2 gene therapy in a surgical minimal residual tumour disease (SMRTD). Mice were inoculated s.c. with methylcholanthrene (MC)-induced MC12 sarcoma cells. When the tumours reached 8 to 12 mm in diameter, they were excised, either completely ("microscopic SMRTD") or incompletely ("macroscopic SMRTD"). On day 90 after surgery, the tumour recurrence rate in untreated mice with microscopic SMRTD was approximately 30%, whereas in those with macroscopic SMRTD it was 75%. After surgery, experimental mice were treated with 2 types of irradiated, IL-2 gene-modified, IL-2-producing tumour cell vaccine. One type of vaccine was derived from the MC12 sarcoma cells (MC12-1L2/IV-3); the other type was derived from an unrelated X63-Ag8.653 plasmacytoma (X63-m-IL-2). Both types of vaccine failed to cure the macroscopic SMRTD. Whereas the X63-m-IL-2 vaccine was also ineffective in the microscopic SMRTD, the MC12-IL2/IV-3 vaccine was capable of preventing growth in all but one mouse (1164) with microscopic SMRTD when administered 2 to 5 days after surgery. If the vaccination took place 2 days before surgery or later than 5 days after surgery, the therapeutic activity was lost. Vaccination with irradiated parental MC12 cells did not produce any significant benefit compared to the operated-only mice. The protective effect of the MC12-L2/IV-3 vaccine was specific and comparatively long-lasting. Vaccinated mice, which had rejected the MC12 tumour residuum, were capable of rejecting a second inoculum of the MC12 sarcoma cells injected on days 35 to 110 after surgery but succumbed to the growth of 2 other unrelated murine sarcomas carrying different tumour-rejection antigens.

journal_name

Int J Cancer

authors

Vlk V,Rössner P,Indrová M,Bubeník J,Sobota V

doi

10.1002/(sici)1097-0215(19980330)76:1<115::aid-ijc

subject

Has Abstract

pub_date

1998-03-30 00:00:00

pages

115-9

issue

1

eissn

0020-7136

issn

1097-0215

pii

10.1002/(SICI)1097-0215(19980330)76:1<115::AID-IJC

journal_volume

76

pub_type

杂志文章
  • Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility.

    abstract::Abnormal survivin expression has been reported to be involved in many types of cancer. A single-nucleotide polymorphism (SNP), C-31G, located in the promoter region of survivin reportedly may alter the mRNA level, while the significance of the nonsynonymous SNP A9194G in exon 4 has not yet been clarified. Here, the as...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.25850

    authors: Kawata N,Tsuchiya N,Horikawa Y,Inoue T,Tsuruta H,Maita S,Satoh S,Mitobe Y,Narita S,Habuchi T

    更新日期:2011-10-15 00:00:00

  • Induction of 2.5 OAS gene expression and activity is not sufficient for IFN-gamma-induced neuroblastoma cell differentiation.

    abstract::We showed earlier that interferon-gamma is a powerful inducer of differentiation of human neuroblastoma (NB) cells. Although 2',5' oligo-adenylate synthetase (2,5 OAS) may play a role in mediating the anti-proliferative and/or differentiative effects of interferons (IFNs), direct evidence is lacking. We have investiga...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910620219

    authors: Corrias MV,Gribaudo G,Guarnaccia F,Ponzoni M

    更新日期:1995-07-17 00:00:00

  • Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.

    abstract::Transforming growth factor-beta (TGF-beta) signaling is initiated following heterodimerization of the type II TGF-beta receptor (TbetaRII) with the type I TGF-beta receptor (TbetaRI). Both receptors are required for TGF-beta responsiveness. In the present study, we characterized the actions of TGF-beta1 in T3M4 human ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0215(19981005)78:2<255::aid-ijc

    authors: Wagner M,Kleeff J,Lopez ME,Bockman I,Massaqué J,Korc M

    更新日期:1998-10-05 00:00:00

  • Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.

    abstract::A carcinogen-induced premalignant oral lesion model that progresses to oral cancer was used to examine the impact of blocking PD-1 on cytokine expression and on progression of lesions to cancer. The results of this study show increased production of IL-2 and the inflammatory cytokines IL-6, IL-17 and TNF-α by spleen c...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.30543

    authors: Levingston CA,Young MR

    更新日期:2017-04-01 00:00:00

  • Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Long-term survival in a randomized study.

    abstract::Although surgical resection is considered the adequate treatment in early stages of nonsmall cell lung cancer, long-term survival is not satisfactory and recurrence rate is high. We previously showed that postoperative chemotherapy at stage IB reduces recurrences and prolongs overall survival. We extended size and obs...

    journal_title:International journal of cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/ijc.21933

    authors: Roselli M,Mariotti S,Ferroni P,Laudisi A,Mineo D,Pompeo E,Ambrogi V,Mineo TC

    更新日期:2006-08-15 00:00:00

  • A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX.

    abstract::The human tumor line LOX was established as an s.c. xenograft in nude mice from a lymph-node metastasis of a patient with malignant melanoma. I.v. injection into adult nude mice of single-cell suspensions prepared from xenografts resulted in progressively growing lung tumor colonies that killed the animals. No differe...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910410322

    authors: Fodstad O,Aamdal S,McMenamin M,Nesland JM,Pihl A

    更新日期:1988-03-15 00:00:00

  • Suppression of lung metastasis of mouse Lewis lung cancer P29 with transfection of the ganglioside GM2/GD2 synthase gene.

    abstract::Ganglioside functions in tumor metastasis were analyzed by carbohydrate remodeling of a mouse Lewis lung cancer (subline P29) by introducing beta1,4GalNAc-T cDNA. Although P29 was originally a low-metastatic subline in the s.c. injection system, it showed high potential in lung metastasis when i.v.-injected via the ta...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.10797

    authors: Chen HH,Fukumoto S,Furukawa K,Nakao A,Akiyama S,Urano T,Furukawa K

    更新日期:2003-01-10 00:00:00

  • Tumoricidal activity of high-dose tumor necrosis factor-alpha is mediated by macrophage-derived nitric oxide burst and permanent blood flow shutdown.

    abstract::This study investigates the role of tumor nitric oxide (NO) and vascular regulation in tumor ulceration following high-dose tumor necrosis factor-alpha (TNF) treatment. Using TNF-responsive (MethA) and nonresponsive (LL2) mouse tumors, tumor NO concentration was measured with an electrochemical sensor and tumor blood ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.23499

    authors: Menon C,Bauer TW,Kelley ST,Raz DJ,Bleier JI,Patel K,Steele K,Prabakaran I,Shifrin A,Buerk DG,Sehgal CM,Fraker DL

    更新日期:2008-07-15 00:00:00

  • PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 status.

    abstract::Protein inhibitor of activated signal transducer and activator of transcription 3 (STAT3) (PIAS3) is an endogenous inhibitor of STAT3 that negatively regulates STAT3 transcriptional activity and cell growth and demonstrates limited expression in the majority of human squamous cell carcinomas of the lung. In this study...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.28448

    authors: Dabir S,Kluge A,McColl K,Liu Y,Lam M,Halmos B,Wildey G,Dowlati A

    更新日期:2014-03-01 00:00:00

  • Spontaneous remission of residual post-therapy plasma Epstein-Barr virus DNA and its prognostic implication in nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis.

    abstract::Detectable post-therapy plasma Epstein-Barr virus (EBV) DNA predicts poor survival in non-metastatic nasopharyngeal carcinoma (NPC). However, some patients subsequently experience spontaneous remission of residual EBV DNA during follow-up and it was unclear whether these patients were still at high risk of disease fai...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.32021

    authors: Zhang Y,Tang LL,Li YQ,Liu X,Liu Q,Ma J

    更新日期:2019-05-01 00:00:00

  • Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.

    abstract::Studies were performed to characterize the effector cells responsible for natural cytotoxicity of mouse lymphoid cells against a variety of syngeneic and allogeneic tumor lines. Since spleen cells from normal nude mice were found to be highly cytotoxic, they were used for most of these experiments. Only a small propor...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910160205

    authors: Herberman RB,Nunn ME,Holden HT,Lavrin DH

    更新日期:1975-08-15 00:00:00

  • Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinoma.

    abstract::The protein C4.4A, a structural homologue of the urokinase-type plasminogen activator receptor, is a potential new biomarker in non-small cell lung cancer, with high levels of expression recently shown to correlate to poor survival of adenocarcinoma patients. In this study, C4.4A immunoreactivity in precursor lesions ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.26305

    authors: Jacobsen B,Santoni-Rugiu E,Illemann M,Kriegbaum MC,Laerum OD,Ploug M

    更新日期:2012-06-01 00:00:00

  • Autoimmune expression of a cytoplasmic protein p60 in mice bearing metastasizing SV40-transformed tumors.

    abstract::In STU mice bearing metastasizing SV40-transformed 51A-232B-M tumors, an immune response against a cellular 60kDa protein (p60) developed in about 50% of the tumor-bearing animals, in addition to the response against SV40 large T-antigen and cellular protein p53. The anti-p60 auto-immune response could be observed as ...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910420620

    authors: Manneck HE,Pfaff M,Anderer FA

    更新日期:1988-12-15 00:00:00

  • Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patients.

    abstract::Although multiple myeloma (MM) is predominantly a disease of the elderly, few studies have focused on the identification of prognostic factors in this group of patients. Four hundred twenty five MM patients >65 years were uniformly treated with chemotherapy (MP or VCMP/VBAD). Multivariate analysis identified 4 factors...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.20491

    authors: García-Sanz R,González-Fraile MI,Mateo G,Hernández JM,López-Berges MC,de las Heras N,Fernández-Calvo J,Ortega F,Portero JA,Bárez A,Galende J,Orfão A,San Miguel JF

    更新日期:2004-12-10 00:00:00

  • Impact of p53-based immunization on primary chemically-induced tumors.

    abstract::In mice as well as humans, cytotoxic T lymphocytes (CTL) specific for wild-type-sequence (wt) p53 peptides have been shown to react against a wide range of tumors, but not normal cells. As such, they are attractive candidates for developing broadly applicable cancer vaccines. Of particular interest is the potential of...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.20686

    authors: Cicinnati VR,Dworacki G,Albers A,Beckebaum S,Tüting T,Kaczmarek E,DeLeo AB

    更新日期:2005-03-01 00:00:00

  • Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: potentiation by Cox-2 inhibition.

    abstract::Paclitaxel has antiangiogenic properties, but the mechanisms for the enhanced sensitivity of endothelial cells (ECs) to this drug are not established. The aims of our study were to compare the distribution of paclitaxel into ECs with other cell types, to assess the effects of low doses of paclitaxel on Cox-2 expressio...

    journal_title:International journal of cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/ijc.20595

    authors: Merchan JR,Jayaram DR,Supko JG,He X,Bubley GJ,Sukhatme VP

    更新日期:2005-01-20 00:00:00

  • Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause.

    abstract::The role of age at menarche and at menopause on epithelial ovarian cancer risk was re-assessed in a combined analysis of 3 hospital-based case-control studies conducted in Italy, the United Kingdom and Greece, which produced a total of 1,140 cases and 2,724 controls. In the overall dataset, there was no evidence of an...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910490111

    authors: Franceschi S,La Vecchia C,Booth M,Tzonou A,Negri E,Parazzini F,Trichopoulos D,Beral V

    更新日期:1991-08-19 00:00:00

  • Humoral cytotoxicity in melanoma patients and its correlation with the extent and course of the disease.

    abstract::Complement-dependent cytotoxicity against melanoma cells was demonstrated with a microassay in sera from melanoma patients. The response was tumor-specific and histologic type-specific since 16 out of 52 (30%) melanoma patient sera taken before surgery reacted against melanoma cells, whereas 3 out of 43 (7%) control s...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910160504

    authors: Canevari S,Fossati G,Della Porta G,Balzarini GP

    更新日期:1975-11-15 00:00:00

  • Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.

    abstract::Nuclear factor-κB (NF-κB) is constitutively activated in many cancers, including oral squamous cell carcinoma (OSCC), and is involved in the invasive characteristics of OSCC, such as growth, antiapoptotic activity and protease production. However, the cellular mechanism underlying NF-κB's promotion of bone invasion by...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.27435

    authors: Furuta H,Osawa K,Shin M,Ishikawa A,Matsuo K,Khan M,Aoki K,Ohya K,Okamoto M,Tominaga K,Takahashi T,Nakanishi O,Jimi E

    更新日期:2012-09-01 00:00:00

  • Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor.

    abstract::The present experiments were performed to investigate the possibility of inhibiting tumor growth in vivo with syngeneic lymphocytes sensitized in vitro on monolayers of the tumor under test, and to study the effect of a thymic humoral factor (THF) in this sensitization process. Monolayers of fibrosarcoma cells were us...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910150612

    authors: Small M,Trainin N

    更新日期:1975-06-15 00:00:00

  • Screening of human brain tumors for SV40-related T antigen.

    abstract::A series of 39 human brain tumors has been screened for the presence or absence of SV40-related T antigen by the direct and indirect immunoperoxidase methods. Two tumors of ependymal origin (malignant ependymoma, choroid plexus papilloma) revealed markedly positive nuclear staining for T antigen both in vivo and in vi...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910210104

    authors: Tabuchi K,Kirsch WM,Low M,Gaskin D,Van Buskirk J,Maa S

    更新日期:1978-01-15 00:00:00

  • BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy.

    abstract::Heat shock protein 90 (Hsp90) is a molecular chaperone that promotes the conformational maturation of numerous client proteins, many of which play critical roles in tumor cell growth and survival. The ansamycin-based Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) is currently in Phase III clinical tes...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.24815

    authors: Yin X,Zhang H,Lundgren K,Wilson L,Burrows F,Shores CG

    更新日期:2010-03-01 00:00:00

  • Recombinant feline viruses containing the myc gene rapidly produce clonal tumours expressing T-cell antigen receptor gene transcripts.

    abstract::We, and others, have recently shown that recombinant feline leukaemia viruses (FeLV) containing the myc gene (FeLV-myc) occur in up to 30% of naturally occurring cases of T-cell lymphosarcoma. Investigation of the disease spectrum of two FeLV-myc isolates showed that they induced clonal or oligoclonal T-cell tumours a...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910400108

    authors: Onions D,Lees G,Forrest D,Neil J

    更新日期:1987-07-15 00:00:00

  • CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.

    abstract::Germline CDKN2A mutations are found in 5-20% of melanoma families. Numerous studies have shown that carriers of CDKN2A mutations have increased risks of non-melanoma cancers, but so far there have been no studies investigating cancer risks in CDKN2A wild type (wt) melanoma families. In this prospective cohort study, i...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.29595

    authors: Helgadottir H,Höiom V,Tuominen R,Jönsson G,Månsson-Brahme E,Olsson H,Hansson J

    更新日期:2015-11-01 00:00:00

  • Modulation of T leukaemic cell phenotype with phorbol ester.

    abstract::A panel of monoclonal antibodies and other markers (e.g., terminal deoxynucleotidyl transferase, sheep erythrocyte rosettes, peanut agglutinin) have been used in conjunction with flow cytometry and biochemical analysis to monitor the induction of maturation in human thymic (T) leukaemic cell lines by phorbol ester (TP...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910290106

    authors: Delia D,Greaves MF,Newman RA,Sutherland DR,Minowada J,Kung P,Goldstein G

    更新日期:1982-01-15 00:00:00

  • Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA).

    abstract::An automated fluorometric microculture cytotoxicity assay (FMCA) based on the measurement of fluorescence generated from cellular hydrolysis of fluorescein diacetate (FDA) to fluorescein was employed for chemotherapeutic-drug-sensitivity testing of tumor-cell suspensions from patients with leukemia. Fluorescence was l...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.2910500204

    authors: Larsson R,Kristensen J,Sandberg C,Nygren P

    更新日期:1992-01-21 00:00:00

  • A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance.

    abstract::Liquid-based cytology (LBC) has replaced conventional cytology (CC) for cervical cancer screening in some countries. However, it remains unclear whether LBC is superior to CC. A randomized controlled trial was conducted between August 2007 and March 2009 in Germany to compare LBC, alone and in combination with compute...

    journal_title:International journal of cancer

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1002/ijc.27955

    authors: Klug SJ,Neis KJ,Harlfinger W,Malter A,König J,Spieth S,Brinkmann-Smetanay F,Kommoss F,Weyer V,Ikenberg H

    更新日期:2013-06-15 00:00:00

  • Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells.

    abstract::The insulin-like growth factors (IGF-I and IGF-II) play a key role in cellular proliferation and are involved in cellular transformation. The expression of the IGF-I receptor has been demonstrated in a variety of human tumor cell lines including ovarian cancer cells. Phosphorothioate antisense oligodeoxynucleotides (S...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0215(19980812)77:4<567::aid-ijc

    authors: Müller M,Dietel M,Turzynski A,Wiechen K

    更新日期:1998-08-12 00:00:00

  • Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.

    abstract::Breast cancer cells frequently metastasize to the skeleton, where they induce OCL formation and activity, resulting in extensive bone destruction. However, the mechanisms by which breast cancer cells mediate increased osteolysis remain unclear. To elucidate this point, we investigated how 3 human breast cancer cell li...

    journal_title:International journal of cancer

    pub_type: 杂志文章

    doi:10.1002/ijc.20056

    authors: Morgan H,Tumber A,Hill PA

    更新日期:2004-05-01 00:00:00

  • Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients.

    abstract::Targeting the GA733 antigen (also known as CO17-1A, EGP, KS1-4, KSA, Ep-CAM) by monoclonal antibody CO17-1A or anti-idiotypic antibodies mimicking the CO17-1A or GA733 epitope has induced prolonged survival and specific immune responses to the antigen, respectively, in colorectal cancer (CRC) patients. In pre-clinical...

    journal_title:International journal of cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Staib L,Birebent B,Somasundaram R,Purev E,Braumüller H,Leeser C,Küttner N,Li W,Zhu D,Diao J,Wunner W,Speicher D,Beger HG,Song H,Herlyn D

    更新日期:2001-04-01 00:00:00